After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Novavax, Inc. is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Novavax, Inc. is $2.31B. A total of 5.21 million shares were traded on the day, compared to an average of 17.12M shares.
In the most recent transaction, YOUNG JAMES F sold 7,500 shares of NVAX for 14.09 per share on Jun 21 ’24. After the transaction, the Director now owns 61,760 company shares. In a previous transaction on Jun 18 ’24, YOUNG JAMES F sold 7,500 shares at 13.72 per share. NVAX shares that Director owns now total 69,260.
Among the insiders who sold shares, Dubovsky Filip disposed of 13,904 shares on Jun 17 ’24 at a per-share price of $14.47. This resulted in the President, R&D holding 66,613 shares of NVAX after the transaction. In another insider transaction, Dubovsky Filip sold 47,312 shares at $13.90 per share on May 14 ’24. Company shares held by the President, R&D now total 38,953.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, NVAX has a high of $23.86 and a low of $3.53.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. NVAX’s latest balance sheet shows that the firm has $1.52B in Cash & Short Term Investments as of fiscal 2021. There were $453.99M in debt and $2.39B in liabilities at the time. Its Book Value Per Share was -$6.18, while its Total Shareholder’s Equity was -$351.67M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NVAX is Buy with a score of 4.00.
